-
The Daily Biotech Pulse: Sangamo In Genome-Editing Therapy Deal With Biogen, FDA Nod For Biohaven, Passage Bio IPO
28 Feb 2020 12:42 GMT
… )
Accelerate Diagnostics Inc (NASDAQ: AXDX)
AcelRx Pharmaceuticals Inc (NASDAQ: ACRX)
Achieve … : GLYC) (before the market open)
IPO
Passage Bio, a biotech developing …
-
The Daily Biotech Pulse: Obseva Sinks On Adverse Clinical Readout, BioNano Surges On Saphyr Adoption, 2 IPOs
07 Nov 2019 12:24 GMT
… -week lows on Nov. 6)
AcelRx Pharmaceuticals Inc (NASDAQ: ACRX)
Achieve … : KIDS) (after the market close)
IPO
Galera Therapeutics priced its 5 … -million share IPO at $12, below the … testing company Centogene priced its IPO of 4 million shares at …
-
Daily Biotech Pulse: Allergan's Depression Drug Flunks Late-Stage Trial, Apellis Offering, ShockWave Medical IPO
07 Mar 2019 13:12 GMT
… : TTOO) (after the market close)
• AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) (after … : SNSS) (after the market close)
IPO
ShockWave Medical, which sells medical …
-
AcelRx Shares React Positively To FDA Committee Briefing On Painkiller Candidate Dsuvia
10 Oct 2018 18:31 GMT
… Advisory Committee, which is evaluating AcelRx Pharmaceuticals Inc (NASDAQ: ACRX … its Buy rating on AcelRX and raised its price … 7 to $10 Wenesday.
AcelRx shares, which were down about … Conferences, Clinical Trial Results And IPOs
© 2018 Benzinga.com. Benzinga …
-
AcelRx Shares React Positively To Tepid FDA Comments On Painkiller Candidate Dsuvia
10 Oct 2018 16:55 GMT
… Advisory Committee, which is evaluating AcelRx Pharmaceuticals Inc (NASDAQ: ACRX … its Buy rating on AcelRX and raised its price … 7 to $10 Wenesday.
AcelRx shares, which were down about … Conferences, Clinical Trial Results And IPOs
© 2018 Benzinga.com. Benzinga …
-
AcelRx Pharmaceuticals Announces Pricing of Public Offering of Common Stock
12 Jul 2018 17:04 GMT
… 2018 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX) today … of customary closing conditions. AcelRx has granted the underwriters a … at the initial public offering price, less the underwriting discounts and commissions.
AcelRx intends …
-
The Week Ahead In Biotech: Conferences, Clinical Trial Results And IPOs
08 Oct 2018 12:37 GMT
… Advisory Committee will also review AcelRx Pharmaceuticals Inc (NASDAQ: ACRX)… being studied for vertigo.
IPOs
Allogene Therapeutics, which develops … million shares in an IPO, with the shares priced … the ticker symbol OSMT.
IPO Quiet Period Expiry
Principia …
-
The Week Ahead In Biotech: Conferences, PDUFA Dates, Earnings And IPOs
28 Jul 2018 18:18 GMT
…
See Also: Tricida Post-IPO Run-up Makes Goldman Wary … : ACOR) (before the open)
AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) (after … Therapeutics Inc (NASDAQ: PETX)
IPO
Bionano Genomics, an instrumentation company … million shares in an IPO, with the price range …
-
The Week Ahead In Biotech: PDUFA Dates, Earnings, IPOs And More
07 May 2018 00:46 GMT
… : NEOS)
Mylan NV (NASDAQ: MYL)
AcelRx Pharmaceuticals Inc (NASDAQ: ACRX)
Adaptimmune … )
Fibrocell Science Inc (NASDAQ: FCSC)
IPO
Immuno-oncology company Abpro is …
-
Bio Roundup: Light For Spark, California Drug Law, IPO Queue & More
13 Oct 2017 11:15 GMT
… and commercialization.
—The FDA told AcelRx Pharmaceuticals (NASDAQ: ACRX) it … approve its opioid painkiller Dsuvia. AcelRx, of Redwood City, CA … treatment.
MONEY IN
—The IPO window remains open to … ).
—More companies joined the IPO queue: Cambridge, MA-based …
About
© 1995-2024